Preprint Review Version 1 This version is not peer-reviewed

Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy and Immune Health

Version 1 : Received: 31 October 2024 / Approved: 31 October 2024 / Online: 1 November 2024 (03:43:18 CET)

How to cite: Gamberi, C.; Leverette, C.; Davis, A. C.; Ismail, M.; Piccialli, I.; Borbone, N.; Oliviero, G.; Vicidomini, C.; Palumbo, R.; Roviello, G. N. Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy and Immune Health. Preprints 2024, 2024102590. https://doi.org/10.20944/preprints202410.2590.v1 Gamberi, C.; Leverette, C.; Davis, A. C.; Ismail, M.; Piccialli, I.; Borbone, N.; Oliviero, G.; Vicidomini, C.; Palumbo, R.; Roviello, G. N. Oceanic Breakthroughs: Marine-Derived Innovations in Vaccination, Therapy and Immune Health. Preprints 2024, 2024102590. https://doi.org/10.20944/preprints202410.2590.v1

Abstract

The vast, untapped potential of the world's oceans is revealing groundbreaking advancements in human health and vaccination. Marine microalgae such as Nannochloropsis spp. and Dunaliella salina are emerging as vital sources for recombinant vaccine development. Various specific and heterologous genetic tools have been generated for Dunaliella salina and Nannochloropsis spp. To boost production of functional recombinant antigens and even the induction of immunoprotective responses. In humans, promising antigens produced in microalgae have shown potential in combating diseases caused by the Human papillomavirus, Human immunodeficiency virus, Hepatitis B virus, Influenza virus, Zika virus, Zaire Ebola virus, Plasmodium falciparum, and Staphylococcus aureus. For animals, microalgae-derived vaccine prototypes have been developed to fight against the Foot and mouth disease virus, Classical swine fever virus, Vibriosis, White spot syndrome virus, and Histophilus somni. Compared to the sources of other drugs, marine organisms offer unique advantages, including the ability to express complex antigens and sustainable production. Additionally, the ocean provides an array of bioactive compounds that serve as therapeutics, potent adjuvants, delivery systems, and immunomodulatory agents. These innovations from the sea not only enhance vaccine efficacy but also contribute to broader immunological and general health. This review explores the transformative role of marine-derived substances in modern medicine, emphasizing their importance in the ongoing battle against infectious diseases.

Keywords

marine microalgae; recombinant vaccines; Nannochloropsis spp.; Dunaliella salina; immunomodulatory agents; vaccine adjuvants

Subject

Biology and Life Sciences, Biology and Biotechnology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.